Related references
Note: Only part of the references are listed.Downregulation of WIF-1 by hypermethylation in astrocytomas
Zhuanyi Yang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2010)
Phase I study of the oral CDK-TRKA inhibitor PHA-848125 in recurrent malignant glioma (MG).
A. Benouaich-Amiel et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Expression and aberrant promoter methylation of Wnt inhibitory factor-1 in human astrocytomas
Zhuanyi Yang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition
David S. Yee et al.
MOLECULAR CANCER (2010)
Wnt Inhibitory Factor 1 Decreases Tumorigenesis and Metastasis in Osteosarcoma
Elyssa M. Rubin et al.
MOLECULAR CANCER THERAPEUTICS (2010)
COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2010)
Differentiation of the brain vasculature: the answer came blowing by the Wnt
Stefan Liebner et al.
VASCULAR CELL (2010)
Structure-activity relationship studies of small-molecule inhibitors of Wnt response
Jianming Lu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
RNOP-09: Pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma - a phase II study
Christoph P. Beier et al.
BMC CANCER (2009)
Functional Significance of Wnt Inhibitory Factor-1 Gene in Kidney Cancer
Kazumori Kawakami et al.
CANCER RESEARCH (2009)
DNA fingerprinting of the NCI-60 cell line panel
Philip L. Lorenzi et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer
Baozhi Chen et al.
NATURE CHEMICAL BIOLOGY (2009)
Modulation of Angiogenic and Inflammatory Response in Glioblastoma by Hypoxia
Anastasia Murat et al.
PLOS ONE (2009)
MAMOT:: hidden Markov modeling tool
Frederic Schuetz et al.
BIOINFORMATICS (2008)
Polycystin-1 C-terminal tail associates with β-catenin and inhibits canonical Wnt signaling
Mark Lal et al.
HUMAN MOLECULAR GENETICS (2008)
Correlation of O6-Methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity
Monika E. Hegi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Stem cell-related Self-Renewal signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma
Anastasia Murat et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Validation of real-time methylation-specific PCR to determine O6-methylguanine-DNA methyltransferase gene promoter methylation in glioma
Ilse Vlassenbroeck et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells
Pantelis Hatzis et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
HOX expression patterns identify a common signature for favorable AML
M. Andreeff et al.
LEUKEMIA (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Downregulation of Wnt signaling is a trigger for formation of facultative heterochromatin and onset of cell senescence in primary human cells
Xiaofen Ye et al.
MOLECULAR CELL (2007)
The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas
Stephen L. Chan et al.
LABORATORY INVESTIGATION (2007)
Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target
S. Horvath et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma
Greg Foltz et al.
CANCER RESEARCH (2006)
Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer
L Ein-Dor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain
LX Sun et al.
CANCER CELL (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Dominant-stable β-catenin expression causes cell fate alterations and Wnt signaling antagonist expression in a murine granulosa cell tumor model
D Boerboom et al.
CANCER RESEARCH (2006)
Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/β-catenin signaling pathway
S Urakami et al.
CLINICAL CANCER RESEARCH (2006)
Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers
H Taniguchi et al.
ONCOGENE (2005)
Gene expression profiling and genetic markers in glioblastoma survival
JN Rich et al.
CANCER RESEARCH (2005)
Sorting points into neighborhoods (SPIN): data analysis and visualization by ordering distance matrices
D Tsafrir et al.
BIOINFORMATICS (2005)
Wnt signalling in stem cells and cancer
T Reya et al.
NATURE (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide
ME Hegi et al.
CLINICAL CANCER RESEARCH (2004)
Gene expression profiling of gliomas strongly predicts survival
WA Freije et al.
CANCER RESEARCH (2004)
Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells
L You et al.
ONCOGENE (2004)
Secreted antagonists of the Wnt signalling pathway
Y Kawano et al.
JOURNAL OF CELL SCIENCE (2003)
The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells
M van de Wetering et al.
CELL (2002)
Wnt/β-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway
EH Jho et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Glycogen synthase kinase-3: Properties, functions, and regulation
A Ali et al.
CHEMICAL REVIEWS (2001)
Share Paper
